101 related articles for article (PubMed ID: 23158633)
1. Vasculitis and panniculitis associated with vemurafenib.
Novoa RA; Honda K; Koon HB; Gerstenblith MR
J Am Acad Dermatol; 2012 Dec; 67(6):e271-2. PubMed ID: 23158633
[No Abstract] [Full Text] [Related]
2. Vemurafenib-induced panniculitis.
Villani AP; Zaharia D; Dalle S; Depaepe L; Balme B; Thomas L
Eur J Dermatol; 2013 Apr; 23(2):258-60. PubMed ID: 23567624
[No Abstract] [Full Text] [Related]
3. Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma.
West ES; Williams VL; Morelli JG
Pediatr Dermatol; 2015; 32(1):153-4. PubMed ID: 24602192
[TBL] [Abstract][Full Text] [Related]
4. Vemurafenib-induced neutrophilic panniculitis.
Monfort JB; Pagès C; Schneider P; Neyns B; Comte C; Bagot M; Vignon-Pennamen MD; Viguier M; Lebbé C
Melanoma Res; 2012 Oct; 22(5):399-401. PubMed ID: 22828248
[TBL] [Abstract][Full Text] [Related]
5. Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib.
Finelt N; Lulla RR; Melin-Aldana H; Ruth JS; Lin FY; Su JM; Pourciau CY; Hunt RD; Kenner-Bell BM
Pediatr Dermatol; 2017 May; 34(3):337-341. PubMed ID: 28523881
[TBL] [Abstract][Full Text] [Related]
6. Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib.
Kim GH; Levy A; Compoginis G
J Cutan Pathol; 2013 Jul; 40(7):667-9. PubMed ID: 23581649
[TBL] [Abstract][Full Text] [Related]
7. Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma.
Pattanaprichakul P; Tetzlaff MT; Lapolla WJ; Torres-Cabala CA; Duvic M; Prieto VG; Tsai KY; Curry JL
J Cutan Pathol; 2014 Mar; 41(3):326-8. PubMed ID: 24372055
[No Abstract] [Full Text] [Related]
8. Panniculitis in patients treated with BRAF inhibitors: a case series.
Choy B; Chou S; Anforth R; Fernández-Peñas P
Am J Dermatopathol; 2014 Jun; 36(6):493-7. PubMed ID: 24879511
[TBL] [Abstract][Full Text] [Related]
9. Vemurafenib-associated neutrophilic panniculitis: An emergent adverse effect of variable severity.
Maldonado-Seral C; Berros-Fombella JP; Vivanco-Allende B; Coto-Segura P; Vazquez-Lopez F; Perez-Oliva N
Dermatol Online J; 2013 Apr; 19(4):16. PubMed ID: 24021375
[TBL] [Abstract][Full Text] [Related]
10. Neutrophilic panniculitis with vasculitis in a melanoma patient treated with vemurafenib: a case report and its management.
Ueno M; Namiki T; Inui K; Hanafusa T; Miura K; Yokozeki H
Int J Dermatol; 2017 Aug; 56(8):e163-e165. PubMed ID: 28244062
[No Abstract] [Full Text] [Related]
11. Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management.
Zimmer L; Livingstone E; Hillen U; Dömkes S; Becker A; Schadendorf D
Arch Dermatol; 2012 Mar; 148(3):357-61. PubMed ID: 22250191
[TBL] [Abstract][Full Text] [Related]
12. Acneiform eruptions associated with vemurafenib.
Petukhova TA; Novoa RA; Honda K; Koon HB; Gerstenblith MR
J Am Acad Dermatol; 2013 Mar; 68(3):e97-9. PubMed ID: 23394928
[No Abstract] [Full Text] [Related]
13. Vemurafenib-induced nonautoimmune haemolytic anaemia.
Fusi A; Hodgetts J; Dennis M; Lorigan P
Melanoma Res; 2014 Aug; 24(4):418-9. PubMed ID: 24992630
[No Abstract] [Full Text] [Related]
14. Focal necrotizing panniculitis and vascular necrosis in rats given subcutaneous injections of cocaine hydrochloride.
Scott DW; Morrell JI; Vernotica EM
J Cutan Pathol; 1997 Jan; 24(1):25-9. PubMed ID: 9027629
[TBL] [Abstract][Full Text] [Related]
15. Vemurafenib-associated pancreatitis: case report.
Muluneh B; Buie LW; Collichio F
Pharmacotherapy; 2013 Apr; 33(4):e43-4. PubMed ID: 23436544
[TBL] [Abstract][Full Text] [Related]
16. Vemurafenib mucosal side-effect.
Pileri A; Cricca M; Gandolfi L; Misciali C; Casadei B; Zinzani PL; Patrizi A
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):1053-5. PubMed ID: 25764320
[No Abstract] [Full Text] [Related]
17. Successful desensitization in a case of Stevens-Johnson syndrome due to vemurafenib.
Minor DR; Rodvien R; Kashani-Sabet M
Melanoma Res; 2012 Oct; 22(5):410-1. PubMed ID: 22828249
[TBL] [Abstract][Full Text] [Related]
18. Sarcoidosis associated with vemurafenib.
Adam A; Thomas L; Bories N; Zaharia D; Balme B; Freymond N; Dalle S
Br J Dermatol; 2013 Jul; 169(1):206-8. PubMed ID: 23834124
[No Abstract] [Full Text] [Related]
19. Vemurafenib-induced pulmonary injury.
Schmitt L; Schumann T; Löser C; Dippel E
Onkologie; 2013; 36(11):685-6. PubMed ID: 24192775
[No Abstract] [Full Text] [Related]
20. Eruptive milia secondary to vemurafenib.
Sambrano BL; Riddel CE; Chon SY
J Am Acad Dermatol; 2013 Nov; 69(5):e258-e260. PubMed ID: 24124854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
